Skip to content

Evaluation of muscle relaxation effect of rocuronium in neonates for emergency surgery

Evaluation of intubating conditions and recovery time with rocuronium in neonates undergoing emergency surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038229
Enrollment
64
Registered
2021-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs Health Condition 2: K318- Other specified diseases of stomach and duodenum Health Condition 3: J988- Other specified respiratory disorders

Interventions

Intervention1: Rocuronium as a muscle relaxant for intubation in neonates undergoing emergency surgery: Rocuronium will be given intravenously in the dose of 0.45mg/kg to achieve muscle relaxation for

Sponsors

Vardhman Mahavir Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Term neonates (0-1 month of age), American Society of Anesthesiologists (ASA) Grade 1 and 2, of either sex, undergoing emergency surgery under general anaesthesia requiring orotracheal intubation

Exclusion criteria

Exclusion criteria: 1. Neonates with anticipated difficult airway 2. Congenital syndromes involving head, neck and cardiovascular system 3. Raised intracranial pressure

Design outcomes

Primary

MeasureTime frame
To evaluate intubating conditions with rocuronium(0.45mg/kg) in neonates and compare it with succinylcholine (2mg/kg)Timepoint: Assessment of intubating conditions will be done at the time of intubation using the Goldberg scale

Secondary

MeasureTime frame
To evaluate recovery time with rocuronium (0.45mg/kg) in neonates at the end of surgeryTimepoint: Recovery time will be measured by time to reversal and time to extubation. Time to reversal: Last skin suture to administration of reversal agents. time to extubation: Last skin suture to time of extubation. Neuro-muscular monitoring and time to achieve TOF ratio greater than 0.7, TOF ratio greater than 0.9 after skin closure will also be noted.

Countries

India

Contacts

Public ContactVanya Chugh

Vardhman Mahavir Medical College and Safdarjung Hospital

vanya_chugh@yahoo.co.in9999977026

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026